MedPath

Glycophos

Glycophos

Approved
Approval ID

dcd92dc7-c6f9-4866-9edd-c95d5097c4e5

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Dec 7, 2022

Manufacturers
FDA

Fresenius Kabi USA, LLC

DUNS: 608775388

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

SODIUM GLYCOLATE

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code63323-241
Product Classification
G
Generic Name
SODIUM GLYCOLATE
Product Specifications
Route of AdministrationINTRAVENOUS
Effective DateJanuary 16, 2019
FDA Product Classification

INGREDIENTS (2)

SODIUM GLYCEROPHOSPHATE ANHYDROUSActive
Quantity: 216 mg in 1 mL
Code: YP1H63LJ2K
Classification: ACTIR
HYDROCHLORIC ACIDInactive
Code: QTT17582CB
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Glycophos - FDA Drug Approval Details